So at the end of November management was saying EBITDA marginally below 25-26m (22nd Nov announcement). Less than 2 months later they are saying EBITDA 8-12m. I guess i have a different meaning of what marginal is. This one is going to take some time before a turn around i feel.
- Forums
- ASX - By Stock
- Ann: FY20 Outlook Update
GTK
gentrack group limited
Add to My Watchlist
1.13%
!
$11.61

So at the end of November management was saying EBITDA...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$11.61 |
Change
0.130(1.13%) |
Mkt cap ! $1.256B |
Open | High | Low | Value | Volume |
$11.45 | $11.78 | $11.34 | $1.411M | 121.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 87 | $11.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.64 | 327 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 187 | 11.630 |
5 | 321 | 11.620 |
5 | 271 | 11.610 |
3 | 173 | 11.600 |
3 | 157 | 11.590 |
Price($) | Vol. | No. |
---|---|---|
11.660 | 223 | 3 |
11.670 | 46 | 1 |
11.680 | 177 | 2 |
11.690 | 1016 | 2 |
11.700 | 180 | 2 |
Last trade - 15.08pm 04/07/2025 (20 minute delay) ? |
Featured News
GTK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online